Today's PR is really important in terms of Acceler
Post# of 1460
(Total Views: 318)
Posted On: 06/21/2021 8:46:19 AM
Today's PR is really important in terms of Accelerated Approval (AA). I hope AVXL applies for it ASAP. The solid data and the fact that there is no other available treatments should bode very well to get FDA support for AA. I followed the AA process with Sarepta closely and it appears the A-273 biomarker data are much stronger. A lot of Retts patients and their families all of a sudden have significant hope.
(1)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼